Pivotal bioVenture Partners Investment Advisor as of Dec. 31, 2024
Portfolio Holdings for Pivotal bioVenture Partners Investment Advisor
Pivotal bioVenture Partners Investment Advisor holds 11 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Vaxcyte (PCVX) | 38.9 | $58M | 704k | 81.86 | |
| Oculis Holding Ordinary Shares (OCS) | 20.0 | $30M | 1.7M | 17.00 | |
| Arcutis Biotherapeutics (ARQT) | 19.9 | $30M | 2.1M | 13.93 | |
| Inozyme Pharma (INZY) | 8.4 | $13M | 4.5M | 2.77 | |
| Zenas Biopharma (ZBIO) | 4.1 | $6.0M | 737k | 8.19 | |
| Recursion Pharmaceuticals In Cl A (RXRX) | 2.7 | $4.0M | 596k | 6.76 | |
| Bioage Labs (BIOA) | 2.6 | $3.8M | 653k | 5.79 | |
| Rallybio Corp (RLYB) | 1.6 | $2.3M | 2.4M | 0.96 | |
| Bolt Biotherapeutics | 0.7 | $1.0M | 1.9M | 0.54 | |
| Vigil Neuroscience (VIGL) | 0.6 | $953k | 561k | 1.70 | |
| Io Biotech (IOBT) | 0.5 | $795k | 864k | 0.92 |
